$4.850
+0.061 (+1.25%)At close
NUS News
NUS Events
Cuts FY26 Revenue View to $1.28B-$1.35B
Cuts FY26 revenue view to $1.28B-$1.35B from $1.35B-$1.5B.
Sees Q3 Revenue of $310M to $340M
Sees Q3 revenue $310M-$340M.
Nu Skin Q1 Revenue at $320.6M, Below Estimate
Reports Q1 revenue $320.6M, one estimate $329.7M. "We delivered first quarter revenue in line with our expectations and made further progress in our strategic priorities while operating in a volatile environment," said Ryan Napierski, Nu Skin president and CEO. "As we move through 2026, we are focused on empowering our sales leaders to scale our intelligent wellness platform with our latest innovation, Prysm iO(TM), ahead of our full consumer rollout in the second half. We also continue to invest in laying the groundwork to expand our presence in emerging markets, including the formal launch of India anticipated in late 2026, while continuing to improve our operational discipline to return value to shareholders."
Sees Q2 Revenue of $330M-$360M
Sees Q2 revenue $330M-$360M, one estimate $361M.
Company Confirms FY26 Revenue Outlook of $1.35B to $1.5B
Backs FY26 revenue view $1.35B-$1.5B, one estimate $1.43B.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.